Drawing for CYTOKIND

USPTO serial 97702604

CYTOKIND

Reviewed by CopyMark Law Group

Status 733Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
NOLASCO-ARIAS, KENNETH E
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 733: Status 733 means the fourth six-month extension was granted. Only one extension typically remains before you must file a Statement of Use or risk abandonment.

Need help with CYTOKIND?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $249*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Derek A. Auito

Derek A. Auito Dentons US LLPP.O. Box 1302Chicago, IL 60604United States

Goods and services

ClassDescriptionStatusFirst use
005Dietary supplement beverage for inflammation, gut dysbiosis; Dietary supplement drink mixes; Dietary supplements; Dietary supplements also containing flavonoids, polyphenols; Dietary supplements consisting primarily of flavonoids, polyphenols; Dietary supplements for human consumption; Dietary supplements for humans; Dietary and nutritional supplements; Dietary and nutritional supplements containing flavonoids, polyphenols; Dietary and nutritional supplements for inflammation, gut dysbiosis; Dietary food supplements; Enzyme dietary supplements; Flavonoids for use as a dietary supplement; Food supplements, namely, anti-oxidants; Herbal supplements for inflammation, gut dysbiosis; Mineral dietary supplements; Natural dietary supplements; Natural dietary supplements for the treatment of inflammation, gut dysbiosis; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for inflammation, gut dysbiosis; Nutritional supplements; Nutritional supplements consisting primarily of flavonoids, polyphenols; Nutritional supplements for inflammation, gut dysbiosis; Powdered nutritional supplement drink mix; Powdered nutritional supplement drink mix containing flavonoids, polyphenols; Prebiotic supplements; Probiotic supplements; Vitamin and mineral supplements, all of the foregoing excluding protein bars and snack barsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 14, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 14, 2026EX4GSOU EXTENSION 4 GRANTED—
May 14, 2026EXT4SOU EXTENSION 4 FILED—
May 14, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 14, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 13, 2025EX3GSOU EXTENSION 3 GRANTED—
Nov 13, 2025EXT3SOU EXTENSION 3 FILED—
Nov 13, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 14, 2025EX2GSOU EXTENSION 2 GRANTED—
May 14, 2025EXT2SOU EXTENSION 2 FILED—
May 14, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 10, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 10, 2024EX1GSOU EXTENSION 1 GRANTED—
Dec 10, 2024AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 12, 2024EXT1SOU EXTENSION 1 FILED—
Nov 12, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 30, 2024CHPBPOST PUBLICATION AMENDMENT - ENTERED—
May 28, 2024APETASSIGNED TO PETITION STAFF—
May 14, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 10, 2024EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Apr 4, 2024ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Oct 25, 2023ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Sep 26, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 26, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 6, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 18, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 14, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Aug 14, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 14, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 14, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 14, 2023DOCKASSIGNED TO EXAMINER—
Dec 29, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 6, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance